Alabama Reaches $276 Million in Opioid-Related Settlements
In mid-April 2022, Alabama announced that it reached $276 million in settlements with Johnson & Johnson, McKesson Corp., and…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Online CME Program Updates Allergists, Dermatologists on New Therapeutic…
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition that can have a significant impact on patient health…
Bipartisan Group of Lawmakers Focused on Decreasing Insulin Prices
A bipartisan group of lawmakers are pushing for bipartisan legislation that would both lower insulin prices and prohibit drug…
Policy and Medicine Compliance Update — Sun Pharma Anti Trust…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
McKinsey – Serving as a Double Agent?
In April 2022, the United States House of Representatives’ Committee on Oversight and Reform issued a report, finding that 22…
COVID Didn’t Seem to Slow Down FDA Drug Approvals
While COVID-19 has impacted almost every facet of our lives over the last few years, one area that it didn’t seem to have a huge…
CMS and HHS Release Notice of Benefit and Payment Parameters Final Rule for…
On April 28, 2022, the United States Centers for Medicare and Medicaid Services (CMS) and Department of Health and Human Services…
Marketers Sentenced for Role in Health Care Kickback Scheme
In mid-April 2022, two marketers were sentenced in federal court to twelve months of probation and hundreds of thousands of…
Amazon Subsidiary Reaches $5.79 Million Settlement Over Insulin Dispensing…
Recently, the Department of Justice (DOJ) announced a $5.79 million settlement with PillPack, an Amazon subsidiary, in a fraud…
California Looking to Add Gender-Affirming CME to Required CME for…
The California Senate Health Committee recently passed a bill through Committee to improve access to gender affirming care. Under…